BUDGET IMPACT ANALYSIS OF PANOBINOSTAT - BORTEZOMIB AND DEXAMETHASONE,
AS 3RD OR 4TH LINE OF TREATMENT IN PATIENTS WITH RELAPSED/REFRACTORY
MULTIPLE MYELOMA IN GREECE
BUDGET IMPACT ANALYSIS OF PANOBINOSTAT - BORTEZOMIB AND DEXAMETHASONE, AS 3RD OR 4TH LINE OF TREATMENT IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA IN GREECE
Γλώσσες Τεκμηρίου:
Αγγλικά
Περίληψη:
Δεν υπάρχει περίληψη
Έτος δημοσίευσης:
2016
Συγγραφείς:
Vellopoulou, K. Kourlaba, G. Delimpasi, S. Chatzikou, M. and Katodritou, E. Konstantopoulou, K. Megalakaki, K. Pouli, A. and Repousis, P. Terpos, E.
